Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double Blind, Placebo Controlled Balanced 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses Of PF-00592379 On Erectile Function, Using 100mg Sildenafil As A Positive Control

NCT00273416 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00273416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00273416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double Blind, Placebo Controlled Balanced 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses Of PF-00592379 On Erectile Function, Using 100mg Sildenafil As A Positive Control
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2006
Completion date
Not reported
Enrollment
32
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

impotence